Levetiracetam
Back to searchMolecule Structure
Scientific Name
Levetiracetam
Description of the Drug
Levetiracetam is a novel anticonvulsant agent used as an adjunct medication to manage partial onset, myoclonic, and generalized tonic-clonic seizures in patients with epilepsy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01202
http://www.drugbank.ca/drugs/DB01202
Brand Name(s)
Desitrend, Elepsia xr, Keppra, Keppra xr, Levetiracetam, Levetiracetam in sodium chloride, Matever, Spritam
Company Owner(s)
Lotus Pharmaceutical Co Ltd Nantou Plant, Alkem Laboratories Ltd, Jubilant Generics Ltd, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Actavis Mid Atlantic Llc, American Regent Inc, Anchen Pharmaceuticals Inc, Xgen Pharmaceuticals Djb Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Synaptic vesicle glycoprotein 2A | SINGLE PROTEIN | MODULATOR | CHEMBL1998 |
| Voltage-gated N-type calcium channel alpha-1B subunit | SINGLE PROTEIN | BLOCKER | CHEMBL4478 |
Clinical Trial(s)
Unichem Links
| Atlas | levetiracetam | |||
| SureChEMBL | SCHEMBL118843 | |||
| DrugBank | DB01202 | |||
| PubChem: Thomson Pharma | 15321885 | 15321884 | ||
| PubChem | 5284583 | |||
| Mcule | MCULE-5120797917 | |||
| LINCS | LSM-5603 | |||
| Nikkaji | J523.599E | |||
| BindingDB | 50422542 | |||
| EPA CompTox Dashboard | DTXSID9023207 | |||
| DrugCentral | 1563 | |||
| Guide to Pharmacology | 6826 | |||
| rxnorm | KEPPRA | ELEPSIA | LEVETIRACETAM | SPRITAM |
| PubChem: Drugs of the Future | 12013706 | |||
| ChEBI | 6437 | |||
| ZINC | ZINC000001547851 |
